New research highlights how uric acid Parkinson's disease protection works through specific cellular pathways. Specifically, investigators analyzed the neuroprotective effects of uric acid (UA) on neuroinflammation and ferroptosis. Furthermore, they used BV2 microglia and mouse models to simulate Parkinson's pathology. Consequently, the results show that UA treatment significantly reduces inflammatory cytokines like TNF-α and IL-6. Additionally, it lowers reactive oxygen species (ROS) and intracellular iron levels. Therefore, UA acts as a powerful neuroprotective agent by preserving mitochondrial integrity.

The Role of Uric Acid Parkinson's Disease and the Nrf2 Pathway

The researchers found that UA activates the Nrf2 signaling pathway to combat cell death. This activation upregulates glutathione peroxidase 4 (GPX4), which is an essential enzyme that prevents ferroptosis. However, using an Nrf2 inhibitor like ML385 eliminated these protective benefits. This confirms that the Nrf2 pathway is mandatory for the therapeutic effects of uric acid. Moreover, UA treatment improved motor performance and preserved dopaminergic neuron density in animal models. These findings provide a clear molecular mechanism for epidemiological observations regarding high serum UA levels and reduced disease risk.

Frequently Asked Questions

How does uric acid protect neurons in Parkinson's disease?

Uric acid acts as a natural antioxidant that activates the Nrf2 signaling pathway. This process reduces neuroinflammation and prevents ferroptosis, an iron-dependent form of cell death commonly found in Parkinson's disease pathology.

What is the relationship between uric acid levels and Parkinson's risk?

Epidemiological studies suggest that individuals with higher serum uric acid levels often have a lower risk of developing Parkinson's disease. They also tend to experience a slower progression of motor symptoms compared to those with lower levels.

Can uric acid supplements be used to treat Parkinson's?

While the laboratory results are promising, clinical trials using inosine to raise uric acid levels have not yet established a definitive clinical benefit for treatment. Always consult a healthcare professional before considering new interventions.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

• Zhou D et al. Uric acid alleviates the inflammatory response in LPS-induced BV2 cells and MPTP-induced PD mice by resisting ferroptosis through the Nrf2 signalling pathway. Redox Rep. 2026 Dec 31. doi: 10.1080/13510002.2026.2668238. PMID: 42241031.


• Gao X et al. Men with high uric acid levels have lower risk for Parkinson's disease. Neurology. 2016;86(6):520-526.


• Bose A, Beal MF. Mitochondrial dysfunction in Parkinson's disease. J Neurochem. 2016;139 Suppl 1:216-231.